How many institutional investors hold ZVRA?

4 tracked institutional investors disclosed a position in ZVRA (ZEVRA THERAPEUTICS INC) in their most recent 13F filing.

Who is the largest institutional holder of ZVRA?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ZVRA, valued at $11M.

Did institutional ownership of ZVRA increase or decrease?

Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited ZVRA.

Where does this ZVRA ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ZVRA — ZEVRA THERAPEUTICS INC

Name: ZEVRA THERAPEUTICS INC (ZVRA) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ZEVRA THERAPEUTICS INC (ZVRA)

ZEVRA THERAPEUTICS INC (ZVRA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $11M. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ZVRA

/100

Mixed Activity

Added / Increased0

Reduced0

Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track ZVRA

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

ZVRA Ownership Composition

How ZEVRA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

64% of tracked value

Institutions

tracked investors

Total Reported

$30.2M

combined 13F value

Other64.2%
Hedge Funds35.8%

Other(3)

64.2%

Hedge Funds(1)

35.8%

Tracked investors reporting ZVRA

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	1.2M	$10.8M	0.01%	Mar 31, 2026
Izzy Englander	Millennium Management	590.3K	$5.5M	0.00%	Mar 31, 2026
Ken Griffin	Citadel Advisors	912.1K	$8.5M	0.00%	Mar 31, 2026
Paul Tudor Jones	Tudor Investment Corp	575.8K	$5.4M	0.01%	Mar 31, 2026

Steve CohenMar 31, 2026
Point72 Asset Management
Shares
1.2M
Value
$10.8M
% Portfolio
0.01%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
590.3K
Value
$5.5M
% Portfolio
0.00%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
912.1K
Value
$8.5M
% Portfolio
0.00%
Paul Tudor JonesMar 31, 2026
Tudor Investment Corp
Shares
575.8K
Value
$5.4M
% Portfolio
0.01%

Recent activity

Investor	Action	Δ %	Current value	Filing date
No recent activity.

No recent activity.

Frequently asked questions

How many institutional investors hold ZVRA?: 4 tracked institutional investors disclosed a position in ZVRA (ZEVRA THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of ZVRA?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ZVRA, valued at $11M.
Did institutional ownership of ZVRA increase or decrease?: Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited ZVRA.
Where does this ZVRA ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.